Urine nucleic acid maker and detection reagent kit for assisting in early screening of prostatic cancer
Patent Information
- Authority / Receiving Office
- CN · China
- Current Assignee / Owner
- 诺迦(杭州)生物工程有限公司
- Publication Date
- 2020-10-16
Smart Images

Figure 1 
Figure 2 
Figure 3
Abstract
Description
Technical field
[0001] The invention relates to the fields of molecular biology and medical diagnostics, in particular to a urine nucleic acid marker and a detection kit for assisting in the early screening of prostate cancer. Background technique
[0002] With the aging of our country's population structure and the changes in people's living habits, prostate cancer has quietly become one of the common tumors that seriously threaten the health of men in our country. The survey results in 2018 showed that the total number of prostate cancer patients in my country was nearly 145,000, and the compound growth rate in the last five years was nearly 10% higher. It is the tumor type with the fastest growing incidence. If prostate cancer is detected early and treated in time, the five-year survival rate can reach more than 95%, while the five-year survival rate of advanced prostate cancer that has metastasized is less than 30%. Only one-quarter to one-third of newly diagnosed patients i...